WallStSmart
AGIO

Agios Pharm

NASDAQ: AGIO · HEALTHCARE · BIOTECHNOLOGY

$28.05
+13.10% today

Updated 2026-04-29

Market cap
$1.67B
P/E ratio
P/S ratio
30.88x
EPS (TTM)
$-7.26
Dividend yield
52W range
$22 – $46
Volume
1.1M

Agios Pharm (AGIO) Financial statements

SEC filings — annual and quarterly data.

Cash flow — annual

Item201120122013201420152016201720182019202020212022202320242025
Operating cash flow$-15.22M$-49.55M$-56.40M$-59.35M$-76.95M$38.56M$-285.23M$-304.42M$-370.62M$-290.76M$-407.32M$-309.48M$-296.06M$-389.84M$-372.98M
Capital expenditures$1.91M$1.48M$1.29M$2.22M$20.16M$9.91M$4.63M$6.99M$12.17M$14.11M$5.74M$4.88M$999000.00$1.69M$4.32M
Depreciation$801000.00$1.18M$1.44M$1.37M$3.34M$5.71M$6.43M$7.17M$8.09M$18.77M$9.24M$8.56M$6.62M$5.65M
Stock-based comp$371000.00$742000.00$3.03M$11.51M$31.96M$42.09M$47.81M$73.36M$72.37M$61.60M$53.51M$49.30M$44.77M$42.85M$52.55M
Free cash flow$-17.13M$-51.02M$-57.69M$-61.57M$-97.11M$28.65M$-289.86M$-311.41M$-382.79M$-304.87M$-413.06M$-314.36M$-297.06M$-391.53M$-377.29M
Investing cash flow$-22.36M$23.04M$-87.22M$-333.34M$128.31M$-119.35M$-57.91M$-273.82M$91.44M$75.75M$1.25B$243.26M$239.57M$363.44M
Financing cash flow$77.36M$142000.00$123.88M$335.16M$6.37M$169.78M$285.11M$546.02M$289.61M$261.52M$-765.77M$2.35M$5.43M$14.44M
Dividends paid$0.00$0.00$0.00$0.00$0.00$37.30M
Share repurchases
Debt repayment
Net change in cash$-19.74M$-57.53M$57.73M$88.99M$-58.03M$-32.22M$10.43M$46.51M$75.69M$-63.87M